Table 1.
Gold compounds | Mechanism of action | Cell or animal models | Reference |
---|---|---|---|
Auranofin | Low dose stimulates NK cells, but high dose inhibits NK cells | NK cells | Russell et al., 1982; Pedersen and Abom, 1986 |
Inhibits the homodimerization of TLR4 and TLR4-mediated activation of key transcription factors (NF-κB, IRF3, COX-2) | Murine pro-B, RAW264.7, 293T, COS-7cells | Jeon et al., 2003; Youn et al., 2006 | |
Suppresses PKC | Human neutrophils | Parente et al., 1989 | |
Activates monocytes to secrete key inflammatory cytokines (IL6, IL8) | THP1 cells | Stern et al., 2005 | |
Inhibits NO and pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) | RAW 264.7 | Han et al., 2008a | |
GST | Activates monocytes to secrete key inflammatory cytokines (IL6, IL8) | THP1 cells | Stern et al., 2005 |
Inhibits PKC, HMGB1 translocation, IFN-beta, NO, and the release of HMGB1 | RAW 264.7, THP-1 cells | Parente et al., 1989; Zetterstrom et al., 2008 | |
AuTM | Activates monocytes and enhances release of superoxide | Human monocytes | Hurst et al., 1986 |
Inhibits CD45 | Wang et al., 1997 | ||
Na3Au (S2O3)2·2H2O | Induces release of IL-8, and expression of CD40 on the surface of DC | DC, PBMC, THP1 cells | Rachmawati et al., 2015b |
HAuCl4 [Au(III)] | Stimulates monocytes to secrete IL6, IL8, and mast cells to degranulate and secrete arachidonic acid metabolites and cytokines (such as IL-4) | THP1, RBL-2H3, HMC-1 cells | Stern et al., 2005; Hayama et al., 2011; Suzuki et al., 2011 |
Aurothioglucose | Inhibits the DNA binding activity of NF-κB | Yang et al., 1995 | |
Gold(I)-triphenylphosphine compounds | Inhibits pro-inflammatory cytokines (TNF-α IL-1β) | THP-1 cells | Krikavova et al., 2014 |
AuTM, sodium aurothiomalate; GST, gold sodium thiomalate; NK cell, natural killer cell; DC, dendritic cell; TLR, toll-like receptor; TNF-α, tumor necrosis factor α; HMGB1, high mobility group box chromosomal protein 1; IL, interleukin; PKC, protein kinase C; IFN, interferon.